Literature DB >> 513071

Chance factors in studies of quantitative structure-activity relationships.

J G Topliss, R P Edwards.   

Abstract

Multiple regression analysis is a basic statistical tool used for QSAR studies in drug design. However, there is a risk or arriving at fortuitous correlations when too many variables are screened relative to the number of available observations. In this regard, a critical distinction must be made between the number of variables screened for possible correlation and the number which actually appear in the regression equation. Using a modified Fortran stepwise multiple-regression analysis program, simulated QSAR studies employing random numbers were run for many different combinations of screened variables and observations. Under certain conditions, a substantial incidence of correlations with high r2 values were found, although the overall degree of chance correlation noted was less than that reported in a previous study. Analysis of the results has provided a basis for making judgements concerning the level of risk of encountering chance correlations for a wide range of combinations of observations and screened variables in QSAR studies using multiple-regression analysis. For illustrative purposes, some examples involving published QSAR studies have been considered and the reported correlations shown to be less significant than originally presented through the influence of unrecognized chance factors.

Mesh:

Year:  1979        PMID: 513071     DOI: 10.1021/jm00196a017

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  60 in total

1.  Evaluation of the EVA descriptor for QSAR studies: 3. The use of a genetic algorithm to search for models with enhanced predictive properties (EVA_GA).

Authors:  D B Turner; P Willett
Journal:  J Comput Aided Mol Des       Date:  2000-01       Impact factor: 3.686

2.  Evaluation of a novel molecular vibration-based descriptor (EVA) for QSAR studies: 2. Model validation using a benchmark steroid dataset.

Authors:  D B Turner; P Willett; A M Ferguson; T W Heritage
Journal:  J Comput Aided Mol Des       Date:  1999-05       Impact factor: 3.686

3.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  J Comput Aided Mol Des       Date:  2002 May-Jun       Impact factor: 3.686

4.  Virtual generation of agents against Mycobacterium tuberculosis. A QSAR study.

Authors:  Emili Besalú; Robert Ponec; Jesus Vicente de Julián-Ortiz
Journal:  Mol Divers       Date:  2003       Impact factor: 2.943

5.  Evaluation of extended parameter sets for the 3D-QSAR technique MaP: implications for interpretability and model quality exemplified by antimalarially active naphthylisoquinoline alkaloids.

Authors:  Nikolaus Stiefl; Gerhard Bringmann; Christian Rummey; Knut Baumann
Journal:  J Comput Aided Mol Des       Date:  2003 May-Jun       Impact factor: 3.686

6.  Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection.

Authors:  Alexander Golbraikh; Alexander Tropsha
Journal:  Mol Divers       Date:  2002       Impact factor: 2.943

7.  Using particle swarms for the development of QSAR models based on K-nearest neighbor and kernel regression.

Authors:  Walter Cedeño; Dimitris K Agrafiotis
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

Review 8.  In silico ADME/Tox: why models fail.

Authors:  Terry R Stouch; James R Kenyon; Stephen R Johnson; Xue-Qing Chen; Arthur Doweyko; Yi Li
Journal:  J Comput Aided Mol Des       Date:  2003 Feb-Apr       Impact factor: 3.686

9.  Validation tools for variable subset regression.

Authors:  Knut Baumann; Nikolaus Stiefl
Journal:  J Comput Aided Mol Des       Date:  2004 Jul-Sep       Impact factor: 3.686

10.  Prediction of glass transition temperatures of OLED materials using topological indices.

Authors:  Jie Xu; Biao Chen
Journal:  J Mol Model       Date:  2005-08-16       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.